Detalhe da pesquisa
1.
In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artigo
Inglês
| MEDLINE | ID: mdl-32071051
2.
Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme.
J Antimicrob Chemother
; 73(9): 2519-2523, 2018 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29912399
3.
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program.
Infect Dis Ther
; 10(4): 2399-2414, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34374952
4.
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
Antimicrob Agents Chemother
; 54(4): 1590-5, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20145089
5.
Safety Profile of Ceftazidime-Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme.
Drug Saf
; 43(8): 751-766, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32602065
6.
Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.
Antimicrob Agents Chemother
; 53(3): 869-75, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19075070
7.
In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART).
Surg Infect (Larchmt)
; 10(2): 99-104, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18831681
8.
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.
Lancet Infect Dis
; 18(3): 285-295, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29254862
9.
Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.
Diagn Microbiol Infect Dis
; 58(4): 491-4, 2007 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-17509789
10.
A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
Int J Antimicrob Agents
; 49(5): 579-588, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28363526
11.
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Int J Antimicrob Agents
; 28(3): 238-43, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16904295
12.
In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Surg Infect (Larchmt)
; 7(6): 537-45, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17233571
13.
Purification, crystallization and preliminary X-ray analysis of Enterococcus faecium aminoglycoside-2''-phosphotransferase-Ib [APH(2'')-Ib].
Acta Crystallogr Sect F Struct Biol Cryst Commun
; 61(Pt 4): 410-3, 2005 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16511055
14.
In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).
Surg Infect (Larchmt)
; 6(4): 439-48, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16433608
15.
Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis.
Clin Infect Dis
; 35(5): 570-5, 2002 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12173131
16.
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
Pediatr Infect Dis J
; 29(5): 415-20, 2010 May.
Artigo
Inglês
| MEDLINE | ID: mdl-20431381
17.
Source of phosphate in the enzymic reaction as a point of distinction among aminoglycoside 2''-phosphotransferases.
J Biol Chem
; 284(11): 6690-6, 2009 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-19158087
18.
Safety experience with caspofungin in pediatric patients.
Pediatr Infect Dis J
; 28(12): 1132-5, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19779392
19.
A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
Pediatrics
; 123(3): 877-84, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19255017
20.
Aminoglycoside 2''-phosphotransferase type IIIa from Enterococcus.
J Biol Chem
; 283(12): 7638-47, 2008 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-18199745